These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 27235844)
1. Offering self-sampling to cervical screening non-attenders in primary care. Lim AW; Hollingworth A; Kalwij S; Curran G; Sasieni P J Med Screen; 2017 Mar; 24(1):43-49. PubMed ID: 27235844 [TBL] [Abstract][Full Text] [Related]
2. HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial. Szarewski A; Cadman L; Mesher D; Austin J; Ashdown-Barr L; Edwards R; Lyons D; Walker J; Christison J; Frater A; Waller J Br J Cancer; 2011 Mar; 104(6):915-20. PubMed ID: 21343937 [TBL] [Abstract][Full Text] [Related]
3. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804 [TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening. Cadman L; Wilkes S; Mansour D; Austin J; Ashdown-Barr L; Edwards R; Kleeman M; Szarewski A J Med Screen; 2015 Mar; 22(1):28-37. PubMed ID: 25403717 [TBL] [Abstract][Full Text] [Related]
6. Feasibility of sending a direct send HPV self-sampling kit to long-term non-attenders in an organized cervical screening program. Sahlgren H; Sparén P; Elfgren K; Miriam Elfström K Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():68-73. PubMed ID: 34875556 [TBL] [Abstract][Full Text] [Related]
7. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme. Bokan T; Ivanus U; Jerman T; Takac I; Arko D Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704 [TBL] [Abstract][Full Text] [Related]
8. Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches. Ivanus U; Jerman T; Fokter AR; Takac I; Prevodnik VK; Marcec M; Gajsek US; Pakiz M; Koren J; Celik SH; Kramberger KG; Klopcic U; Kavalar R; Zatler SS; Kuzmanov BG; Florjancic M; Nolde N; Novakovic S; Poljak M; Zakelj MP Radiol Oncol; 2018 Sep; 52(4):399-412. PubMed ID: 30216191 [TBL] [Abstract][Full Text] [Related]
9. Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network Across Rural Greece: The GRECOSELF Study. Agorastos T; Chatzistamatiou K; Tsertanidou A; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moysiadis T; Moschaki V; Skenderi A; Katsiki E; Aggelidou S; Venizelos I; Ntoula M; Daponte A; Vanakara P; Garas A; Stefos T; Vrekoussis T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Manidakis G; Deligeoroglou E; Panoskaltsis T; Decavalas GO; Michail G; Kalogiannidis I; Koukoulis G; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Chronopoulou A; Vaitsi V; Chatzaki E; Paschopoulos M; Adonakis G; Kaufmann AM; Hadzidimitriou A; Stamatopoulos K Cancer Prev Res (Phila); 2019 Oct; 12(10):701-710. PubMed ID: 31427275 [TBL] [Abstract][Full Text] [Related]
10. Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study. El-Zein M; Bouten S; Louvanto K; Gilbert L; Gotlieb W; Hemmings R; Behr MA; Franco EL; Gynecol Oncol; 2018 Jun; 149(3):491-497. PubMed ID: 29678360 [TBL] [Abstract][Full Text] [Related]
11. Opportunistic offering of self-sampling to non-attenders within the English cervical screening programme: a pragmatic, multicentre, implementation feasibility trial with randomly allocated cluster intervention start dates (YouScreen). Lim AWW; Deats K; Gambell J; Lawrence A; Lei J; Lyons M; North B; Parmar D; Patel H; Waller J; Warwick J; Sasieni PD; EClinicalMedicine; 2024 Jul; 73():102672. PubMed ID: 39429813 [TBL] [Abstract][Full Text] [Related]
12. Urine collection in cervical cancer screening - analytical comparison of two HPV DNA assays. Tranberg M; Jensen JS; Bech BH; Andersen B BMC Infect Dis; 2020 Dec; 20(1):926. PubMed ID: 33276740 [TBL] [Abstract][Full Text] [Related]
13. Effect of vaginal self-sampling on cervical cancer screening rates: a community-based study in Newfoundland. Duke P; Godwin M; Ratnam S; Dawson L; Fontaine D; Lear A; Traverso-Yepez M; Graham W; Ravalia M; Mugford G; Pike A; Fortier J; Peach M BMC Womens Health; 2015 Jun; 15():47. PubMed ID: 26060041 [TBL] [Abstract][Full Text] [Related]
14. Acceptance of Self-Sampling Among Long-Term Cervical Screening Non-Attenders with HPV-Positive Results: Promising Opportunity for Specific Cancer Education. Andersson S; Belkić K; Mints M; Östensson E J Cancer Educ; 2021 Feb; 36(1):126-133. PubMed ID: 31522376 [TBL] [Abstract][Full Text] [Related]
15. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening. Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615 [TBL] [Abstract][Full Text] [Related]
16. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084 [TBL] [Abstract][Full Text] [Related]
17. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. Gök M; Heideman DA; van Kemenade FJ; Berkhof J; Rozendaal L; Spruyt JW; Voorhorst F; Beliën JA; Babovic M; Snijders PJ; Meijer CJ BMJ; 2010 Mar; 340():c1040. PubMed ID: 20223872 [TBL] [Abstract][Full Text] [Related]
18. Self-collected cervicovaginal sampling for site-of-care primary HPV-based cervical cancer screening: a pilot study in a rural underserved Greek population. Chatzistamatiou K; Chatzaki Ε; Constantinidis Τ; Nena E; Tsertanidou A; Agorastos T J Obstet Gynaecol; 2017 Nov; 37(8):1059-1064. PubMed ID: 28631511 [TBL] [Abstract][Full Text] [Related]
19. [A feasibility study on cervical screening in non-attenders invited to undergo HPV self-sampling with cytology triage versus repeat invitation for cytology screening in Hokkaido]. Taniguchi S; Sakuragi N; Hanley SJB; Tsukiyama K; Fujita H; Sagae S; Kajii N; Watari H; Tamakoshi A Nihon Koshu Eisei Zasshi; 2021 Dec; 68(11):719-727. PubMed ID: 34373426 [TBL] [Abstract][Full Text] [Related]
20. Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology. Zehbe I; Jackson R; Wood B; Weaver B; Escott N; Severini A; Krajden M; Bishop L; Morrisseau K; Ogilvie G; Burchell AN; Little J BMJ Open; 2016 Oct; 6(10):e011754. PubMed ID: 27855089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]